Comparative Clinical Study of Intraocular Lens Injectors Lioli™, Pioli™, and Pioli™ Plus
Recruiting
Observational Study
Cataract
Lens Implantation, Intraocular
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 40 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 120 (estimated)
- Sponsor
- AST Products, Inc. · Industry
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this observational study is to evaluate whether different intraocular lens (IOL) injectors affect surgical outcomes in patients aged 40 and older undergoing cataract surgery. The main questions it aims to answer are:
* Do different IOL injectors change the size of the corneal incision during surgery?
* Do the injectors lead to different rates of complications during or after surgery? …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age 40 years or older
* Scheduled for cataract surgery using phacoemulsification technique
* Planned implantation of an Asqelio™ monofocal intraocular lens (IOL)
* Clear intraocular media, except for the presence of cataract (i.e., no other significant ocular opacities)
Exclu…
Contacts